Will Henan Ling Rui Pharmaceutical Company go bankrupt?

Henan Ling Rui Pharmaceutical Company will not go bankrupt. The first quarterly report of Ling Rui Pharmaceutical in 2022 showed that the company's main income was 682 million yuan, up 65,438+05.73% year-on-year. The net profit returned to the mother was 65,438+0.365,438+0 billion yuan, a year-on-year increase of 35.4438+0%. Deducting non-net profit was 65.438+0.05 billion yuan, a year-on-year increase of 654.38+0.599%. In the first quarter of 2022, the company's main revenue in a single quarter was 682 million yuan, a year-on-year increase of 65,438+05.73%. The net profit attributable to the mother in a single quarter was 1.3 1 100 million yuan, a year-on-year increase of 35,438+0%. The non-net profit deducted in a single quarter was 65.438+0.05 billion yuan, a year-on-year increase of 654.38+0.599%. The debt ratio is 39.89%, the investment income11772,500 yuan, the financial expenses-3,642,800 yuan, and the gross profit margin is 74.98%.